Pinkerton Retirement Specialists, LLC Eli Lilly & CO Transaction History

Pinkerton Retirement Specialists, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $58,627 - $78,435	-99 Reduced 14.6%	579 $450,000
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $356,078 - $419,770	678 New	678 $395,000
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $723,767 - $850,030	2,330 Added 84.09%	5,101 $1.75 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $73,956 - $86,174	230 Added 9.05%	2,771 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $753,355 - $858,527	2,541 New	2,541 $822,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Pinkerton Retirement Specialists, LLC, based on Form 13F filings with the SEC.

Stay updated on Pinkerton Retirement Specialists, LLC with notifications on news.